Diverging Opinions Persist On Thorny EU Regulatory Trilogue Subjects
This article was originally published in Clinica
Executive Summary
As predicted, the challenging issues of scrutiny for high-risk devices, liability insurance, and genetic counselling were tackled during the first medtech regulatory trilogue, held on Feb 17, under the Dutch Presidency of the Council of the EU.